HCC biomarkers – state of the old and outlook to future promising biomarkers and their potential in everyday clinical practice

Hepatocellular carcinoma (HCC) is one of the most common and deadly tumors worldwide. Management of HCC depends on reliable biomarkers for screening, diagnosis, and monitoring of the disease, as well as predicting response towards therapy and safety. To date, imaging has been the established standar...

Descripción completa

Detalles Bibliográficos
Autores principales: Schlosser, Sophie, Tümen, Deniz, Volz, Barbara, Neumeyer, Katja, Egler, Niklas, Kunst, Claudia, Tews, Hauke Christian, Schmid, Stephan, Kandulski, Arne, Müller, Martina, Gülow, Karsten
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9742592/
https://www.ncbi.nlm.nih.gov/pubmed/36518320
http://dx.doi.org/10.3389/fonc.2022.1016952

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9742592/
https://www.ncbi.nlm.nih.gov/pubmed/36518320
http://dx.doi.org/10.3389/fonc.2022.1016952

Ejemplares similares